Cargando…
Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
Rapamycin protects mice against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced loss of dopaminergic neurons, which is an established model for Parkinson's disease. We demonstrated that rapamycin preserves astrocytic expression of glutamate transporters and glutamate reuptake. The p...
Autores principales: | Zhang, Yunlong, He, Xiaoliang, Wu, Xiaojuan, Lei, Ming, Wei, Zhiyun, Zhang, Xiuping, Wen, Lei, Xu, Pingyi, Li, Shaomin, Qu, Shaogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386462/ https://www.ncbi.nlm.nih.gov/pubmed/28182002 http://dx.doi.org/10.1038/cddis.2016.491 |
Ejemplares similares
-
Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model
por: Zhang, Yunlong, et al.
Publicado: (2017) -
Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease
por: Zhang, Yunlong, et al.
Publicado: (2016) -
The Accessibility in the External Part of the TM5 of the Glutamate Transporter EAAT1 Is Conformationally Sensitive during the Transport Cycle
por: Zhang, Xiuping, et al.
Publicado: (2012) -
TM4 of the glutamate transporter GLT-1 experiences substrate-induced motion during the transport cycle
por: Rong, Xiuliang, et al.
Publicado: (2016) -
Proximity of Transmembrane Segments 5 and 8 of the Glutamate Transporter GLT-1 Inferred from Paired Cysteine Mutagenesis
por: Zhang, Xiuping, et al.
Publicado: (2011)